Publications by authors named "Barbara Peil"

Claim this Profile
V
Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial.
Muhammad Shahzeb Khan, Stefan D Anker, Gerasimos Filippatos, João Pedro Ferreira, Stuart J Pocock, Barbara Peil

J Card Fail· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacodynamics and pharmacokinetics following once-daily doses of BI 187004, an inhibitor of 11 beta-hydroxysteroid dehydrogenase-1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity.
Susanna Bianzano, Matias Nordaby, Leona Plum-Mörschel, Barbara Peil, Tim Heise

Diabetes Obes Metab· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced.
Stefan D Anker, Muhammad Shahzeb Khan, Javed Butler, Anne Pernille Ofstad, Barbara Peil

Eur J Heart Fail· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally Clinically Important Difference in Health Status Scores in Patients With HFrEF vs HFpEF.
Javed Butler, Muhammad Shahzeb Khan, JoAnn Lindenfeld, William T Abraham, Gianluigi Savarese, Barbara Peil

JACC Heart Fail· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, Martina Brueckmann, Michael Böhm, Barbara Peil

Circulation· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.
Subodh Verma, Nitish K Dhingra, Javed Butler, Stefan D Anker, Joao Pedro Ferreira, Barbara Peil

Lancet Diabetes Endocrinol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials.
Stefan D Anker, Piotr Ponikowski, Christoph Wanner, Egon Pfarr, Sibylle Hauske, Barbara Peil

Circulation· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial.
Javed Butler, Stefan D Anker, Gerasimos Filippatos, Muhammad Shahzeb Khan, João Pedro Ferreira, Barbara Peil

Eur Heart J· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes.
William T Abraham, JoAnn Lindenfeld, Piotr Ponikowski, Piergiuseppe Agostoni, Javed Butler, Barbara Peil

Eur Heart J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Diclofenac + Capsaicin Gel in Patients with Acute Back/Neck Pain: A Multicenter Randomized Controlled Study.
Hans-Georg Predel, Caty Ebel-Bitoun, Barbara Peil, Thomas W Weiser, Robert Lange

Pain Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.
Heinz-Josef Lenz, Guillem Argiles, Takayuki Yoshino, Sara Lonardi, Alfredo Falcone, Barbara Peil

Clin Colorectal Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failure.
William T Abraham, Piotr Ponikowski, Martina Brueckmann, Cordula Zeller, Hemani Macesic, Barbara Peil

Eur J Heart Fail· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung.
Shun Lu, Wei Li, Caicun Zhou, Cheng-Ping Hu, Shukui Qin, Barbara Peil

Onco Targets Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring mutations: subgroup analysis of the LUX-Lung 6 trial.
Yi-Long Wu, Chong-Rui Xu, Cheng-Ping Hu, Jifeng Feng, Shun Lu, Barbara Peil

Onco Targets Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.
Yi-Long Wu, Lecia V Sequist, Eng-Huat Tan, Sarayut L Geater, Sergey Orlov, Barbara Peil

Clin Lung Cancer· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtypes of Native American ancestry and leading causes of death: Mapuche ancestry-specific associations with gallbladder cancer risk in Chile.
Justo Lorenzo Bermejo, Felix Boekstegers, Rosa González Silos, Katherine Marcelain, Pablo Baez Benavides, Barbara Peil

PLoS Genet· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using next-generation DNA sequence data for genetic association tests based on allele counts with and without consideration of zero inflation.
Rosa González Silos, Özge Karadag, Barbara Peil, Christine Fischer, Maria Kabisch

BMC Proc· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atlas of the clinical genetics of human dilated cardiomyopathy.
Jan Haas, Karen S Frese, Barbara Peil, Wanda Kloos, Andreas Keller

Eur Heart J· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailored selection of study individuals to be sequenced in order to improve the accuracy of genotype imputation.
Barbara Peil, Maria Kabisch, Christine Fischer, Ute Hamann, Justo Lorenzo Bermejo

Genet Epidemiol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical investigation of the performance of robust logistic regression to predict the genetic risk of hypertension.
Miriam Kesselmeier, Carine Legrand, Barbara Peil, Maria Kabisch, Christine Fischer

BMC Proc· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy.
Benjamin Meder, Frank Rühle, Tanja Weis, Georg Homuth, Andreas Keller, Barbara Peil

Eur Heart J· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headache.
Bernhard Aicher, Hubertus Peil, Barbara Peil, Hans-Christoph Diener

Cephalalgia· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis